Sitai: Proposed acquisition of a 20% stake in Jiangsu Ruishi Pharmaceutical Co., Ltd. for 10 million yuan

2026-03-25 22:41:27

Si Tai Li announces that the company plans to acquire a 20% stake in Jiangsu Ruishi Pharmaceutical Co., Ltd. held by Li Yongping for 10 million yuan. Ruishi Pharmaceutical was established on June 9, 2025, with a registered capital of 10 million yuan, and its legal representative is Zhang Qing. As of December 31, 2025, Ruishi Pharmaceutical’s total assets were 5.1529 million yuan, owner’s equity was 470,500 yuan, operating income for 2025 was 2.8442 million yuan, and net profit was 105,500 yuan. This transaction does not constitute an associated transaction nor a major asset reorganization as defined by the Administrative Measures for Major Asset Restructuring of Listed Companies.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.